previous arrow
next arrow
Slider

产品介绍

路明克斯公司的xTAG™ 和 MultiCode®-RTx 技术灵敏度及准确性高,应用领域广泛,适用于高通量及高速度的检测。

了解更多

科学研究

您对自行研发以满足实验需求及技术指标感兴趣吗?路明克斯公司的xMAP®技术可以为您的多重检测提供一个灵活及应用广泛的平台。

了解更多

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology.
Click here to start the conversation now.

了解更多

Luminex Blog

Luminex Licensed Technologies Partner Spotlight: EpiCypher

EpiCypher delivers high-quality reagents for epigenetics and chromatin research

As one of Luminex’s Licensed Technologies Partners, EpiCypher is one of many companies that uses xMAP® Technology to deliver important solutions for improving research and molecular diagnostics. Based out of the Research Triangle Park in North Carolina, EpiCypher is a biotechnology company that helps scientists push the boundaries of research in chromatin regulation, chromatin mapping, and epigenetics.

Continue Reading >

xMAP TECHNOLOGY OVERVIEW

 

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Luminex on Twitter


The @US_FDA has approved the drug Veklury (Remdesivir) for the treatment of COVID-19 requiring hospitalization. It is the first treatment to receive FDA approval. Read more here: https://t.co/xhVd57GsGS https://t.co/M0OBR9L0h0
h J R
@IDSE_Online: Using a rapid molecular diagnostic assay to identify VRE cut in-hospital mortality rates by nearly 80%. https://t.co/VbnGm4zeyl @UTexasPharmacy @Luminex #rapiddiagnostics #IDWeek2020
h J R
In this new @FrontImmunol study, multiplex immunoassays offer advantages for measuring cytokines in human plasma, which can be useful in diagnosing, tracking, & treating health disorders. Read the study here: https://t.co/CQmQPYALSL https://t.co/fF7RTw6Xen
h J R